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Abstract
In specific cell types like keratinocytes, Notch signaling plays an important pro-differentiation and tumor suppressing
function, with down-modulation of the Notch1 gene being associated with cancer development. Besides being controlled
by p53, little else is known on regulation of Notch1 gene expression in this context. We report here that transcription of this
gene is driven by a TATA-less ‘‘sharp peak’’ promoter and that the minimal functional region of this promoter, which
extends from the 2342 bp position to the initiation codon, is differentially active in normal versus cancer cells. This GC rich
region lacks p53 binding sites, but binds Klf4 and Sp3. This finding is likely to be of biological significance, as Klf4 and, to a
lesser extent, Sp3 are up-regulated in a number of cancer cells where Notch1 expression is down-modulated, and Klf4 over-
expression in normal cells is sufficient to down-modulate Notch1 gene transcription. The combined knock-down of Klf4 and
Sp3 was necessary for the reverse effect of increasing Notch1 transcription, consistent with the two factors exerting an
overlapping repressor function through their binding to the Notch1 promoter.
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Introduction
Notch signaling plays a key role in control of cell fate
determination, growth and differentiation [1,2]. It is also a
determinant of carcinogenesis, with either a positive or negative
role depending on cell type and specific context [3,4]. The best
characterized ‘‘canonical’’ pathway of Notch activation involves
proteolytic cleavage and translocation of the cytoplasmic domain
of the receptor to the nucleus, where it associates with the DNA
binding protein CSL converting it from a repressor into an
activator of transcription [1,2]. Most attention has been given to
control of the Notch pathway at the post-transcriptional level,
including processing and maturation of Notch receptors, activa-
tion by ligands at the cell surface, and protein modification and
degradation [1,2]. However, a main form of regulation can also be
at the level of gene transcription. Expression of the four Notch
receptor genes and their ligands is regulated in specific cellular
contexts and can be altered in cancer development [3,5].
Furthermore, activation of one receptor is susceptible of affecting
its own expression as well as of other family members, and can also
impinge, in a positive or negative manner, on ligand expression
[1,2].
An example of this complex mode of regulation of Notch
expression has been provided by studies in keratinocytes, where
this pathway plays a key role in promoting differentiation and
suppressing tumorigenesis [3]. In the basal layer of the epidermis,
reciprocal negative regulation between ligands of the Delta family
and Notch receptors has been proposed to control the balance
between putative keratinocyte stem cell populations and cells
committed to differentiation [6]. On the other hand, positive
feedback regulation between Notch receptors and ligands of the
Jagged family has been implicated as a possible mechanism for
synchronization of the keratinocyte transition from the basal
proliferating to suprabasal differentiating layers of the epidermis
[7]. While both Notch1 and Notch2 receptors are expressed in the
interfollicular epidermis, their regulation and function are only
partially overlapping. In particular, while Notch2 levels are
uniformly elevated in the differentiating layers of the epidermis,
expression of Notch1 is shut off in the outermost layers [7]. This
may be of functional importance, since elevated Notch1 activity,
while required for commitment and entry into differentiation, can
then suppress the latest steps of this process [7,8]. Similarly, in
keratinocyte-derived tumors, like cutaneous squamous cell carci-
nomas (SCCs), basal cell carcinomas (BCCs) [9,10] and late stage
cervical carcinomas [11], Notch1 expression is decreased to a
substantially greater extent than Notch2. This is of likely
functional significance as, even in the presence of Notch2, deletion
of the Notch1 gene is by itself sufficient to promote keratinocyte
tumor development [9,11,12].
Surprisingly little is know on control of Notch1 gene expression.
In keratinocytes, endogenous p53 binds to the Notch1 promoter,
increasing its transcription, and compromised p53 function can
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explain, at least in part, the tumor-associated down-modulation of
Notch1 expression [9,13,14]. Similarly, decreased p53 levels via
viral E6-dependent degradation can explain the already men-
tioned down-regulation of Notch1 expression in HPV-positive
cervical carcinoma cells [14]. Control of Notch1 expression by p53
is also of relevance for the keratinocyte response to UV light, a
major etiological agent of skin aging and cancer [13,14]. Besides
keratinocytes, and their malignant counterparts, Notch1 expres-
sion is under positive p53 control in lung and prostate cancer cells,
other cell types in which increased Notch signaling causes growth
suppression [15], as well as in B-cell chronic lymphocytic leukemia
cells, where Notch signaling enhances cell survival [16]. In many
of these cases, p53 was found to be specifically involved in control
of the Notch1 gene with little or no effects on other family
members [9,14,15]. Interestingly, no such regulation was found in
colon carcinoma cells, in spite of binding of p53 to the Notch1
promoter even in these cells, pointing to the likely interplay
between p53 and other as yet unidentified determinants of Notch1
gene transcription [9].
The Sp/KLF family of transcription factors consists of proteins
with three highly conserved DNA-binding zinc finger domains,
which recognize GC/CACCC boxes present in many GC-rich
promoters [17]. These factors play an important role in
transcription of housekeeping genes as well as genes with more
restricted cell type specific functions [18]. Among Klf family
members, Klf4 has attracted recent attention because of its
capability, in concert with other factors, to reprogram cell fate
determination [19], as well as promoting or suppressing cancer
development in a context dependent manner [20]. We report here
that in keratinocytes Klf4 binds to the Notch1 promoter and,
together with Sp3, functions as a negative regulator of Notch1
gene transcription, affecting recruitment of the PolII preinitiation
complex through a separate mechanism from p53. Inhibition of
Notch1 expression by Klf4 is consistent with the essential role of
Klf4 in the late stages of keratinocyte differentiation [21], for
which expression of the Notch1 gene needs to be turned off [7].
However, the same regulatory mechanism can also contribute to
down-modulation of Notch1 expression in keratinocyte-derived
tumors, where Klf4 can be aberrantly over-expressed.
Results
1. Transcription of the Notch1 gene from a ‘sharp peak’
TATA less promoter
Besides the involvement of p53 [9,13,14,22], little is known on
control of Notch1 gene transcription. The human Notch1 gene is
located on chromosome 9 and structured in 34 exons, which code for
a large protein of about 270 kDa. For further insights into
transcriptional control of this gene, we compared its upstream non-
coding sequence in the human versus mouse genomes. Several
predicted p53 binding sites are present in the 3.0 kb upstream
sequence of the mouse and human Notch1 promoters although at
different positions relative to the initiation codon (Fig. 1A). A gradient
of increasing sequence homology was found towards the human and
mouse initiation codons, with.70% of sequence identity in the GC-
rich domain from position2500 bp to the ATG. Nucleotide analysis
further pointed to a putative TFIID-binding site around position
2230 bp surrounded by distal core elements, while no TATA boxes
could be identified (using the TESS, Consite or Genomatix programs;
www.cbil.upenn.edu/cgi-bin/tess/tess; asp.ii.uib.no:8090/cgi-bin/
CONSITE/consite; www.genomatix.de) (Fig. 1B).
To establish experimentally the transcription start site (TSS) of
the Notch1 transcript in primary human keratinocytes (HKC), we
cloned and sequenced the products of 59-RACE (Rapid amplifi-
cation of 59 complementary DNA ends) reaction from these cells
(Fig. 1C). The results pointed to a main TSS of the human Notch1
gene at position 2262 bp from the ATG, with a second minor
TSS at 2259 bp. Thus, transcription of the Notch1 gene is driven
by a CpG island promoter, which, unlike most promoters of this
class [23], has the characteristics of a ‘sharp peak’ promoter, with
precise TSSs probably determined by an overlapping initiator (Inr)
element [24].
2. Mapping of the functional Notch1 promoter region in
normal versus cancer cells
mRNA expression can be controlled at multiple levels, from the
first steps of transcription (initiation/elongation) to RNA process-
ing and stability [25]. Real time RT-PCR analysis with primers
specific for the 59 and 39 regions of the Notch1 transcript and first
intron showed that the higher expression of Notch1 mRNA
previously reported in HKC versus keratinocyte-derived cancer
cells [9,11] was maintained irrespectively of the specific regions of
the Notch1 transcript that were analyzed (Fig. 2).
These results suggested that transcription of the Notch1 gene is
differentially controlled in normal versus cancer cells already at the
initial steps of transcription. To further test this possibility, we
determined the minimal functional region of the Notch1 promoter
and assessed whether such region is differentially active in normal
versus cancer cells. For this purpose, the 2.4 kb region of the
Notch1 promoter upstream of the initiation codon was cloned into
a luciferase reporter, followed by promoter activity assays in
HKCs versus HeLa cells. Testing a series of fragments with
progressively reduced length from the 59 end showed that a
342 bp region from the initiation codon retains full promoter
activity in HKCs, while further shortening of the Notch1 promoter
to 2315 bp and 2300 bp regions resulted in progressively
reduced activity (Fig. 3A). Notch1 promoter regions with full
activity in HKCs were significantly less active in HeLa cells,
reflecting the differences in endogenous Notch1 gene transcrip-
tion, while the difference in promoter activity became less with
shorter Notch1 promoter fragments (Fig. 3A).
Nucleotide sequences downstream of transcription start sites
(TSS) play also an important role in control of promoter activity,
being required for the formation of the transcription pre-initiation
and initiation complexes [26]. Consistent with the importance of
this region, promoter activity was substantially decreased when the
sequence of the Notch1 promoter downstream of the TSS to the
initiation codon (from 2262 to 21) was partially or totally deleted
(with promoter constructs lacking nucleotides 2159 to 21, and
2262 to 21, respectively) (Fig. 3B). Even in this case, intrinsically
decreased promoter activity was accompanied by a lesser
difference between normal and cancer cells (Fig. 3B).
PCR amplification of genomic DNA, aimed at assessing its
methylation state as shown further below, revealed the existence of a
small deletion in the Notch1 promoter region of two different strains
of HeLa cells, which was not present in other cancer cells like PC3
and Caski (Fig. 3C). By cloning and sequencing this region, we
mapped the deletion to the 2215 to 2202 bp position, just
downstream of the TSS. Functional promoter activity assays of the
cloned promoter region promoter in HKC versus HeLa cells showed
that this 10 nucleotides deletion did not affect promoter activity nor
its differential regulation in normal versus cancer cells (Fig. 3D).
3. Negative control of Notch1 gene transcription by Klf4
and Sp3
The differential transcription activity of the GC-rich proximal
region of the Notch1 promoter may be linked to a different
Notch1 Gene Transcription
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methylation state in HKCs versus HeLa cells. Pull down assays with
antibodies against methylated DNA followed by PCR amplification
pointed to a substantial level of methylation of the first intronic
region (between nucleotides +1168/+1798) in Hela cells but not in
HKCs, which could contribute to different transcription of the
Notch1 gene (Fig. 4A). However, no detectable methylation was
found in the Notch1 promoter region that may account for its
different levels of activity in the two cells. Another possibility is that
the differential Notch1 promoter activity is linked to transcription
factors that bind to this region and control its activity. Transcription
factors with the highest probability to bind to GC rich domains like
the one present in the Notch1 promoter proximal region are zinc-
finger proteins of the Sp- and KLF families [27]. One or more of
these factors may be differentially expressed in normal versus cancer
cells. In fact, real time RT-PCR of HKCs versus a panel of cervical
carcinoma and keratinocyte-derived SCC cells showed that, of the
several Sp/KLF family members that were examined, Klf4 was
strongly and consistently up-regulated in cancer cells (Fig. 4B). Sp1
and Sp3 were also up-regulated in these cells, although to a lesser
extent than Klf4, while expression of other family members, like
KLF5, or KLF10a was only slightly affected and/or down-
modulated (Fig. 4B). Lesser differences were observed at the protein
level, probably as the result of post-transcriptional and/or protein
destabilization events (Fig. 4C).
To assess the functional consequences of increased Klf4 expression
on Notch1 transcription, two complementary approaches were
undertaken. In the first, HKCs were transiently transfected with a
Notch1 reporter; promoter activity was suppressed by concomitant
transfection with a Klf4 expression vector (Fig. 5A). As a second
approach, HKCwere infected with a Klf4 expressing retrovirus. Real
Figure 1. Characterization of the upstream region of the Notch1 gene. (A) Nucleotide sequence comparison of the 3.0 kb upstream region
of the human and mouse Notch1 genes, with increasing homology towards the coding region illustrated by a grey intensity gradient. The position of
putative p53-binding sites, as predicted by a bioinformatics program (MatInspector, http://www.genomatix.de) is indicated, relative to the initiation
codon. ‘‘Canonical’’ p53-binding sites are composed of two half-sites with the nucleotide sequence RRRCA/T-T/AGYYY (with R = purine; and Y =
pyrimidine), separated by a spacer of 0–21 nucleotides. Quarter-sites (RRRCW and WGYYY) can be present in a head to head, or head to tail
orientation, as indicated by arrows (R orr). Numbers above and below refer to the matching score between the nucleotide sequence of each site
and the predicted matrix, with a perfect match= 1.00, and a ‘‘good’’ match .0.80. (B) Core promoter elements of the human Notch1 gene with an
indication of the GC-rich proximal region, putative TFIID binding site and distal core elements (DCE) [53] (as identified by the TESS program) and
Notch1 transcription start sites (TSS). (C) Experimental determination of the Notch1 TSS by 59 RACE. Human primary keratinocytes were used as
source of total RNA for 59 RACE amplification using GeneRacer and a specific reverse primer located at +242 bp from the initiation codon. Cloning
and sequencing of the amplification reaction product (as shown after gel electrophoresis) pointed to a major TSS at position 2262 and a second at
position 2259. The sequence of overlapping initiator elements (Py Py A(+1) N T(+3) Py Py), in our case TCA(+1)CT(+3)AG for the major TSS, and
CTA(+1)GT(+3)GC for the second TSS, is indicated in bold, while the first nucleotides of the two TSS are in Italics.
doi:10.1371/journal.pone.0010369.g001
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time RT-PCR as well as immunoblot analysis showed that
endogenous Notch1 expression was significantly reduced in these
cells as a consequence of Klf4 over-expression (Fig. 5B, C).
Conversely, to test whether Klf4 suppression leads to Notch1
up-regulation, HKC as well as HeLa cells were transfected with
siRNAs for Klf4. Efficient down-modulation of this gene had no
effects on Notch1 gene transcription, and similar lack of effects was
observed after knock-down of Sp3 and Sp1 (Fig. 6A and data not
shown). However, the combined siRNA-mediated knockdown of
Klf4 and Sp3 resulted in consistent up-regulation of Notch1
expression in both HKCs and cancer cells (HeLa and SCC13
cells), with the concomitant knock-down of Sp1 having no
additional effects (Fig. 6B, C and data not shown).
The required combined knockdown of Klf4 and Sp3 for up-
regulation of Notch1 expression may be explained by the
concomitant binding of these factors to the Notch1 promoter. In
fact, chromatin immunoprecipitation (ChIP) assays showed, in
HKCs and HeLa cells, that both Klf4 and Sp3 bind the GC rich
proximal region of the Notch 1 promoter (Fig. 7A-D). Interest-
ingly, in HKCs, Sp1 was also found to bind to this region, but to a
much lesser extent than to the proximal region of the p21WAF1/
Cip1 promoter, a well established Sp1 target [28]. No Sp1 binding
to the Notch1 promoter was found in HeLa cells (Fig. 7B). Similar
Chip assays were also performed with antibodies against an
unrelated GC-binding transcription factor, Maz [29]. While Maz1
was found to bind to the p21 promoter similarly to Sp1, Sp3 and
Klf4, there was little or no binding of this protein to the proximal
region of the Notch1 promoter (Fig. 7B, C).
4. Opposite control of Notch1 transcription by p53 versus
Klf4/Sp3
An important question is whether p53 and Klf4/Sp3 control
Notch1 gene transcription through separate or convergent
Figure 2. Transcription of various regions of the Notch1 gene in primary human keratinocytes versus keratinocyte-derived cancer
cell lines. (A) Organization of the Notch1 gene, with an indication of the open reading frame (ORF) with coding exons and intervening introns (black
thick boxes and lines, respectively) and 59 and 39 untranslated regions (UTR). The position of the different sets of primers utilized for real time RT-PCR
analysis is also indicated (thin arrows). (B) Total RNA from primary human keratinocytes (HKC), cervical carcinoma cells (HeLa, Caski and SiHa), and skin
(SCC13) and oral (SCCO28) squamous carcinoma cells was analyzed by real-time RT-PCR with primers corresponding to different region of the Notch1
gene as indicated in (A). For this and all other figures, values were normalized to 36B4 and/or 18S RNA levels, and expressed as relative to those in
primary keratinocytes.
doi:10.1371/journal.pone.0010369.g002
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Figure 3. Mapping of the minimal functional region of the Notch1 promoter in primary human keratinocytes versus HeLa cells. (A)
Different fragments of the human Notch1 promoter with decreasing 59 ends were cloned into a luciferase reporter plasmid, followed by transient
transfection into primary human keratinocytes and HeLa cells (black and grey bars, respectively) together with a Renilla minimal reporter for
normalization. Promoter activity was measured 48 hours after transfection. Relative promoter activity of the various reporters in HKC versus HeLa was
also calculated (right Table). (B) Fragments of the human Notch1 promoter with partial or total deletion of the sequence from the TSS to the initiation
codon (lacking nucleotides 2159 to 21, and 2262 to 21, respectively) were cloned into a luciferase reporter plasmid, followed by transient
transfection/promoter activity assays in primary human keratinocytes and HeLa cells as in the previous panel. Relative promoter activity in HKC versus
HeLa was also calculated. (C) Total RNA from primary keratinocytes and various cancer cells lines, including PC3, Caski, and HeLa from two different
sources (HeLa#1 and 2), was utilized for RT-PCR amplification of the 59 UTR region of the Notch 1 gene (primer position2262/2174). Note the faster
migrating band obtained with the HeLa samples. Cloning and sequencing of the overlapping genomic region (from position 2392 bp to 21 of the
Notch1 promoter) showed a deletion from position2215 to2202 in HeLa cells. (D) The same Notch1 genomic region plus/minus the above deletion
was cloned into a luciferase reporter plasmid, followed by promoter activity assays in HKC versus HeLa cells, measured as in (A) and (B).
doi:10.1371/journal.pone.0010369.g003
Notch1 Gene Transcription
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mechanisms. A key regulatory step is transcription factor-
dependent recruitment of the transcription pre-initiation complex,
containing RNA Polymerase II (PolII), to target promoters [30].
To assess whether this initial step of Notch1 transcription is under
p53 and Klf4/Sp3 control, two complementary approaches were
undertaken. In HeLa cells, where p53 levels are very low due to
E6-dependent degradation, we evaluated the effects of increased
p53 by adenoviral-mediated over-expression. In control HeLa
cells, ChIP assays showed little or no binding of PolII to the
promoter and 39UTR of the Notch1 gene, while such binding was
readily detectable in cells with increased p53 expression (Fig. 8A).
In HKC, where levels of Klf4 are normally low, we evaluated the
effect of increased Klf4 expression via retroviral infection. ChIP
assays showed binding of PolII to the promoter and the 39UTR
of the Notch1 gene in control HKCs, while no such binding
was detectable in cells with increased Klf4 expression
(Fig. 8B).
Functionally, to assess whether increased p53 expression and
Klf4/Sp3 down-modulation can synergize, two complementary
approaches were undertaken. In the first, HeLa cells were infected
with a p53 expressing adenovirus plus/minus knock-down of Klf4
and Sp3 expression. In the second, HeLa cells were transfected
with siRNAs specific for the UBE3A protein, a negative regulator
of p53 stability, as a method to increase endogenous p53
expression [14]. Increased p53 levels by either approaches caused
the expected induction of Notch1 expression. The combined
knockdown of Klf4 and Sp3 caused also an increase of Notch1
expression, but no additive or synergistic effects were observed by
Figure 4. Methylation state of the Notch1 regulatory region and expression of various Sp/KLF family members in primary
keratinocytes versus keratinocyte-derived cancer cell lines. (A) Nuclear extracts from primary human keratinocytes (HKC) and HeLa cells were
immunoprecipitated with antibodies against methylated DNA, followed by PCR analysis of the precipitated DNA with primers specific for the
indicated regions of the Notch1 promoter and first intronic region. PCR with primers specific for a known methylated gene was used as positive
control. (B) Total RNA samples from primary human keratinocytes (HKC) and the indicated cancer cell lines were analyzed by real time RT-PCR with
primers specific for Sp1, Sp3, Klf4, KLF5 and KLF10a. (C) Primary keratinocytes, HeLa and SCC13 cells were analyzed by immunoblotting with
antibodies against Sp1, Sp3 and Klf4, with b-actin as equal loading control.
doi:10.1371/journal.pone.0010369.g004
Notch1 Gene Transcription
PLoS ONE | www.plosone.org 6 April 2010 | Volume 5 | Issue 4 | e10369
the concomitant increased of p53 and the knock-down of Klf4 and
Sp3 (Fig. 9A and B).
To assess whether Klf4 can suppress the inductive effects of p53,
HKCs, HeLa and SCC13 cells were infected with the Klf4
expressing retrovirus or empty vector control, followed by
infection with the p53 expressing adenovirus or GFP control.
Increased p53 levels caused induction of Notch1 expression in
control HKCs as well as in HKCs where the Notch1 gene was
down-modulated as a consequence of increased Klf4 expression
(Fig. 9C). A more substantial induction of Notch1 expression was
caused by Ad-p53 infection of cancer cells, like HeLa and SCC13
cells, which share a mutated or silent p53 pathway and low
endogenous Notch1 levels [9,11]. In these cells, which express high
level of endogenous Klf4, further expression of Klf4 did not
decrease Notch1 expression and did not interfere with its
induction by p53 (Fig. 9D).
Thus, p53 and Klf4 converge on control of Notch1 gene
transcription at the initial step of PolII recruitment, with p53
induction occurring through a separate mechanism from Klf4/
Sp3 repression.
Discussion
Tumor suppressor genes are classically defined as genes whose
mutation or loss is required for tumor development [31]. The
importance of transcriptional down-regulation of these genes is
being increasingly recognized [32]. In specific cell types like
keratinocytes, Notch signaling plays an important pro-differenti-
ation and tumor suppressing function [3,33], which is associated
with specific down-modulation of the Notch1 gene in keratinocyte-
derived cutaneous squamous cell carcinomas (SCCs) [9] and basal
cell carcinomas (BCCs) [10], as well as in late stage cervical
carcinomas, another important form of keratinocyte-derived
tumors [11,14]. Besides being controlled by p53 in keratinocytes
and other cell types where Notch1 may play a growth/tumor
suppressing function [34], little else is known on regulation of
Notch1 gene expression. Very recently, negative control of Notch1
transcription by the Id3 repressor has been implicated as a
requisite step for T cell maturation [35]. We have shown here that
transcription of this gene is driven by a TATA-less ‘‘sharp peak’’
promoter and that the minimal functional region of this promoter,
which extends from the -342 bp position to the initiation codon, is
differentially active in normal versus cancer cells. This GC rich
region lacks p53 binding sites, but binds Klf4 and Sp3. This
finding is likely to be of biological significance, as Klf4 and, to a
lesser extent, Sp3 are up-regulated in a number of cancer cells
where Notch1 expression is down-modulated, and Klf4 over-
expression in normal cells is sufficient to down-modulate Notch1
gene transcription. The combined knock-down of Klf4 and Sp3
was necessary for the reverse effect of increasing Notch1
transcription, consistent with the two factors exerting an
overlapping repressor function through their binding to the
Notch1 promoter.
Regulation of transcription occurs at multiple levels, with
recruitment of the transcriptional machinery to the initiation site
being a key step [30]. We have shown here that p53 and Klf4/Sp3
converge on recruitment of PolII to the Notch1 promoter, with
one promoting and the other suppressing this event. The human
Notch1 promoter region contains different putative p53-binding
sites, which consist of single and double half-sites, each composed
of two quarter-sites with a head-to-head orientation [36] (Fig. 1).
Besides the quarter-site orientation, another factor affecting
strength of p53 regulation is the distance between its cis-element
binding elements and the transcription start site. DNA looping
allows tetramer formation by p53 bound to distant and proximal
promoter sites, thereby enhancing the impact on transcription. In
the absence of proximal p53 binding sites, association with other
proteins may mediate the juxtaposition of p53 to the transcription
initiation complex [36]. A well established example of a p53
bridging protein is Sp1 [37], which is antagonized by Sp3, in a
gene and promoter specific manner [27]. An interesting possibility
was that of a p53/Sp1 versus Klf4/Sp3 antagonism applying to
control of the Notch1 promoter proximal region that we have
Figure 5. Negative control of Notch1 gene expression by Klf4. (A) Primary keratinocytes were co-transfected with a reporter containing the
minimal functional Notch1 promoter (from -392pGL4) together with an expression vector for human Klf4 or empty vector control. Renilla minimal
reporter was used for internal normalization, and the promoter activity was measured 48 hours after transfection. Shown are the results of two
different experiments. (B) Primary keratinocytes were infected with a retroviral vector expressing KlfF4 (pMSKlf4) or an empty vector control and
harvested after 48 hours, followed by determination of Klf4 and Notch1 mRNA expression by real-time PCR. Efficiency of infection with the pMSKlf4
virus was also assessed by the widespread morphological changes with flattening of cells (upper panels). (C) Primary keratinocytes were infected with
a KlfF4 expressing retrovirus versus an empty vector control as in the previous panel, followed by immunoblot analysis with antibodies against
Notch1, Klf4 and c-tubulin as equal loading control. Right panel: data were quantified by densitometric scanning of the autoradiograph and
expressed as arbitrary units after normalization for c-tubulin expression. Similar results were obtained in a second independent experiment.
doi:10.1371/journal.pone.0010369.g005
Notch1 Gene Transcription
PLoS ONE | www.plosone.org 7 April 2010 | Volume 5 | Issue 4 | e10369
Figure 6. Up-regulation of Notch1 gene expression by Klf4 and Sp3 knock down. (A) Primary keratinocytes were transfected with two sets
of siRNAs for Klf4, Sp1 or Sp3 in parallel with scrambled siRNA controls for 48 hours, followed by expression analysis of the targeted genes by real
time RT-PCR and immunoblotting (left and middle panels, respectively) The same RNA samples were also analyzed for levels of Notch1 expression
(right panel). (B) Primary keratinocytes, were transfected as in the previous panel with two different sets of siRNAs for Klf4 and Sp3 (siRNA-1, siRNA-2)
(left columns) or with siRNAs for Klf4, Sp1 and Sp3 (right columns), followed by real time RT-PCR analysis of Notch1 expression. Shown is the
Notch1 Gene Transcription
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studied. However, even in normal cells, Sp1 was found to bind to
this region to a much lesser extent than to the p21 proximal
promoter, a well established Sp1 binding region [28]. In addition,
knock down of Sp1 had no effect on basal levels of Notch1 gene
transcription or its induction by p53. Conversely, the combined
knock down of Klf4 and Sp3 resulted in increased Notch1
expression not only in normal keratinocytes but also in cancer cells
like SCC13 and HeLa, where p53 is mutated and/or very lowly
expressed. Thus, control of Notch1 gene transcription by Klf4 and
Sp3 is likely to occur through a separate parallel mechanism from
that by p53.
While originally identified for its general transcription house-
keeping function, genetic studies have demonstrated that Sp1, and
its related Sp3 family member, play a surprisingly specific and
essential function during development [38,39]. In keratinocytes,
these factors have been implicated in control of differentiation
marker genes like involucrin [40], loricrin [41] and SPRR [42] as
well as p21 [28], which, besides its role in the cell cycle, plays a
crucial role in the differentiation-associated transcription program
[43]. In these cells, as in other contexts, Sp1 and Sp3 can play
distinct regulatory functions, with Sp1 acting as an activator, and
Sp3 as either an activator or repressor of transcription.
Like Notch1, Klf4 plays a highly context-dependent function in
growth/differentiation control, being capable of both promoting
and suppressing these processes even within the same cell type,
depending on stages of development and in normal versus
pathological conditions [20]. The dual function of this factor has
been well demonstrated in the keratinocyte/skin system. Genetic
deletion experiments have showed that Klf4 plays an essential
positive role in the late steps of keratinocyte differentiation
required for epidermal barrier formation [21]. However, Klf4 is
also often over-expressed in keratinocyte-derived squamous cell
carcinomas [44], and initial stages of carcinogenesis [45], with
keratinocyte-specific transgenic expression promoting skin tumor
formation [46]. Other tumor types have also been variously
associated with increased or decreased Klf4 expression and
function [20]. Recently, in RK3E cells, an E1a immortalized rat
kidney cell line in which both Klf4 and Notch1 activation lead to
transformation, Klf4 was shown to induce Notch1 expression [47].
The underlying mechanism involves also, as we have shown here,
direct binding of Klf4 to the Notch1 promoter [47], pointing to the
existence of additional cell type specific determinants of Klf4
function as either positive or negative regulator of Notch1
transcription.
A common feature of transcription networks is the presence of
feedback regulatory loops used for amplification of an initial signal
through positive reinforcement, or the dampening or termination
of a signaling cascade, through negative regulation [48]. Thus,
Notch1, besides being a downstream target of Klf4, may also be
involved in control of this latter molecule. This appears to be the
case in intestinal goblet cells in which Klf4 expression, essential for
differentiation, is under negative Notch control [49,50,51]. In our
system, activated Notch1 expression did not exert any significant
effects on Klf4 expression (data not shown), but this may still occur
under other experimental conditions and/or in vivo.
Biologically, inhibition of Notch1 expression by increased Klf4
levels is consistent with the essential role of the latter factor in late
stages of keratinocyte differentiation [21], where expression of the
Notch1 gene needs to be turned off [7,8]. However, Notch1
expression can also become aberrantly suppressed by Klf4 during
cancer development. As such, our findings indicate that the same
regulatory mechanisms that trigger the final stages of the terminal
differentiation process can also promote cancer development by
suppressing the intermediate commitment stages (for which
Notch1 is required).
Materials and Methods
Cells and viruses
Primary human keratinocytes and cancer cell lines were cultured
as previously described [22]. The Ad-p53 virus was a gift of Dr. S.
Lee (Massachusetts General Hospital, Charleston, MA), and the
pMX-Klf4 retroviral vector [52] was obtained from Addgene.
Conditions for adeno- and retro-virus production and infection, and
for siRNA transfection were as previously described [9].
Plasmids
The Notch1 promoter regions 22472/21 and 2392/21
(numbered relative to the ATG) were amplified by PCR from HKs
or HeLa (referred as 2392 (D-215-202) in the text) genomic DNA
with the primer pairs 59-CTGCCTCCCGACCTGTAGGAG-39
and 59-GCCTCCCCACCGGCTGCCCTC-39, and 59-CTCGG-
GGAGGCGCAAAGGCGG-39 and 59-GCCTCCCCACCGGC-
TGCCCTC-39, and subcloned into the pGL4 vector (Promega)
using the KpnI/NheI sites. The 2358/21, 2342/21, 2315/21
and 2300/21 Notch1 promoter regions were amplified by PCR
from the 2392pGL4 clone using the reverse primer 59-
GCCTCCCCACCGGCTGCCCTC-39 in combination with the
following forward primers: 59-GAGGAGGTGGCCGCGGAG-39,
59-agggggcggggggaccggcg-39, 59-ggccgggcggggcggggccggc-39 and 59-
ggccggcgggggcggagcgcacc-39 respectively. The inserts were subse-
quently subcloned in the pGL4 vector using the KpnI/NheI sites.
The 2530/21 Notch1 promoter region was isolated using the
previously cloned 2976/21 Notch1 promoter region cut with
BamHI and NcoI and subcloned in the pGL4 vector through BglII/
NcoI sites. The 2530/2159 fragment was derived from the 2530/
21 clone, by cutting with KpnI and SmaI, and inserted in the pGL4
vector using the KpnI/EcoRV sites. The2530/2262 fragment was
derived from the 2530/21 clone, by cutting with KpnI and SpeI,
and inserted in the pGL4 vector using the KpnI/NheI sites. The
human cDNA clone for Klf4 was obtained from Origene
(TC117491).
RACE
Total RNA was treated with calf intestinal pyrophosphatase
(CIP) to remove the 59 phosphates of truncated mRNA, and with
tobacco acid pyrophosphatase (TAP) to remove the 59 cap
structure from intact, full-length mRNA. GeneRacer RNA Oligo
(Invitrogen) was ligated to the 59 end of the mRNA using T4
ligase. Reverse transcription using random primers created
RACE-ready first-strand cDNA with known priming sites at the
59 end. The first-strand cDNA was amplified later on with the
GeneRacer 59 Primer (homologous to the GeneRacer RNA Oligo)
and the reverse gene-specific primer located at the position +242
calculated average of four different experiments using 36b4 and 18S RNA for internal normalization. (C) HeLa and SCC13 cells were transfected with
two different sets of siRNAs for Klf4 and Sp3 (siRNA-1, siRNA-2) followed by determination of Notch1 expression by real-time RT-PCR as in the
previous panel. Primary keratinocytes and SCC13 cells were transfected with siRNAs against the indicated genes followed by immunoblot analysis of
Notch1 protein expression with c-tubulin as equal loading control. Right panel: data were quantified by densitometric scanning of the
autoradiograph and expressed as arbitrary units after normalization for c-tubulin expression.
doi:10.1371/journal.pone.0010369.g006
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Figure 7. Binding of endogenous Klf4 and Sp1/Sp3 proteins to the Notch1 promoter. (A) Predicted Klf4- and Sp1/Sp3 binding sites in the
2340/2300 bp Notch1 promoter region. Shown is the nucleotide sequence of this region with, on top, the predicted binding sites for Klf4- and Sp1/
Sp3. (B and C) Primary keratinocytes (HKC) and HeLa cells were processed for chromatin immunoprecipitation (ChIP) analysis with antibodies against
Sp1, Sp3 (B), Klf4 (C) or Maz, as indicated, followed by amplification of two Notch1 promoter regions located between bp 2740/2262 (Chip 1) and
around 26600 bp (Chip 2), which contain and lack, respectively, putative Sp1/Sp3 and Klf4 binding sites. Amplification of the proximal promoter
region of the p21WAF1/Cip1 gene (Chip p21) was used as positive control. Un-precipitated chromatin preparations were used for parallel amplification
reactions as ‘input’ DNA controls. (D) Chip assays with anti-Sp3 and Klf4 antibodies and non immune IgGs as in the previous panels were followed by
real time PCR amplification of region1 of the Notch1 promoter. The amount of precipitated DNA was calculated relative to the total input chromatin
and expressed as a percentage of the total according to the following formula [54]: percentage total = 2DCt65, where DCt = Ct (input) 2 Ct
(immunoprecipitation), and Ct is the cycle threshold.
doi:10.1371/journal.pone.0010369.g007
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bp for the downstream transcription (59-CTCTGCGGTCCAC-
CACGTGGCATGT-39) and at the position -1136 bp for the
upstream transcription (59-GTGCCTGGCATCGTGGTGGA-
GAA-39). RACE PCR products were purified using S.N.A.P.
columns and run on an agarose gel. The bands were cut, cloned
into the pCR4-TOPO vector (Invitrogen) and subsequently
sequenced.
Promoter activity assays
Cells were plated onto 12-well dishes and transfected with 2 mg
of luciferase reporter plasmid and 20 ng of phRLTK (Promega) as
internal control, using Lipofectamine 2000 (Invitrogen) according
to the manufacturer’s instructions. Cells were lysed with Passive
Lysis Buffer, and luciferase activity measured with Dual-Lucifer-
ase/Renilla Reporter Assay System (Promega) 48 hours after
transfection. All conditions were tested in triplicate wells and
relative values were normalized for Renilla luciferase activity.
Lysate proteins were quantified with Bradford reagent as a second
normalization. All experiments were repeated at least three times.
Real time RT-PCR
Conditions for total cell RNA preparations and real time RT-
PCR were as previously described [9], using an Icycler IQ Real-
Time Detection System (Bio-Rad) according to the manufacturer’s
recommendations, with SYBR Green (Bio-Rad) for detection.
Amplification of the same cDNAs with human 18S or 36b4
primers was used for internal normalization. Total RNA was
extracted and purified from different cell types and conditions with
Figure 8. Opposite control of PolII recruitment to the Notch1 promoter by p53 and Klf4. (A) HeLa cells were infected with a recombinant
adenovirus expressing wild-type p53 (Adp53) or GFP control (AdGFP) and processed for ChIP assays with antibodies against RNA polymerase II (a-
PolII) and non-immune IgGs as control. PCR amplification of the indicated regions of the Notch1 gene was performed, in parallel with similar
amplification of the input chromatin DNA. Right panels: for quantification of the results, the chromatin immunoprecipitated material was also
analyzed by real time PCR amplification of the indicated regions of the Notch1 promoter, in parallel with input chromatin DNA, followed by a
calculation of binding according to the same formula utilized in Fig. 7D. (B) Primary keratinocytes (HKC) were infected with a retroviral vector over-
expressing Klf4 (pMSKlf4) or empty vector control (Ctrl) for 48 hours followed by ChIP assays for PolII binding as in the previous panel, including
quantification of the results by real time PCR (right panels).
doi:10.1371/journal.pone.0010369.g008
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TRI-reagent (Sigma) and DNase I treated following the manu-
facturer’s instructions. 1 mg of total RNA was used to synthesize
cDNA with random hexamer primers and SuperScript RNAse H-
Reverse Transcriptase (Invitrogen). cDNA production was mon-
itored with control b-actin PCR amplification. Real-time PCR was
performed. Each sample was tested in triplicate with gene-specific
primers (see supporting information, Table S1).
Chromatin immunoprecipitation (ChIP)
HKCs and HeLa cells were cross-linked in 1% formaldehyde
for 5 and 10 min respectively. Nuclei were extracted by incubation
of cells for 5 min using cold L1 solution (50 mM Tris pH 8, 2 mM
EDTA, 0.1% NP-40, 10% glycerol) followed by treatment with L2
solution (1% SDS, 5 mM EDTA, 50 mM Tris pH 8). Nuclei were
sonicated so that the average length of chromosomal DNA became
200–1000 bp. 1 ml of chromatin solution was precleared with
80 ml of 50% protein G–Sepharose slurry pretreated with 1 mg/
ml sonicated salmon sperm DNA. DNA/protein complexes were
precipitated by overnight incubation with 8 mg anti-Sp1 (PEP-2,
Santa Cruz Biotechnology), 4 mg anti-Sp3 (D-20, Santa Cruz
Biotechnology), 4 mg anti-Klf4 (H-180, Santa Cruz Biotechnolo-
gy), 4 mg anti-PolII (N-20; Labforce) and 4 mg anti-MAZ (H-50,
Santa Cruz Biotechnology) antibody or 4 mg normal rabbit anti-
IgG antibodies as control (Santa Cruz Biotechnology). DNA/
protein complexes were incubated with 30 ml of 50% protein G–
Sepharose pretreated with salmon sperm DNA, followed by
reversal of cross-links and deproteination. After phenol–chloro-
form extraction and ethanol precipitation, the recovered DNA was
analyzed by PCR amplification. Preliminary experiments with
naked DNA were carried out to optimize PCR conditions for each
target sequence. The promoter for the Notch1 human gene
contains several Sp/KLF-binding sites. All PCRs for the GC-rich
Notch1 promoter sequence were performed using GC-rich PCR
kit system (Roche).
Immunoblots and antibodies
Conditions for immunoblotting were as previously described
[9]. The following antibodies were used: goat polyclonal anti-
Notch1 (C-20; Santa Cruz Biotechnology), rabbit polyclonal anti-
Sp1, anti-Sp3, anti-Klf4 (Santa Cruz Biotechnology), anti-PolII
and mouse monoclonal anti-c-tubulin (Sigma), secondary HRP-
conjugated antibodies (Amersham Bioscience). Signal was detected
using SuperSignal West Pico Chemiluminescent Substrate (Pierce).
Supporting Information
Table S1 List of primers for RT-PCR and real-time RT-PCR,
and siRNAs (Stealth RNAi).
Figure 9. Separate control of Notch1 transcription by Klf4/Sp3 and p53. (A) HeLa cells were transfected with siRNAs for Sp3 and Klf4 in
parallel with scrambled siRNA controls followed, 48 hours after transfection, by infection with a p53 expressing adenovirus (Adp53) or GFP control
(AdGFP), for 24 hours. Levels of Notch1 mRNA expression were determined by real-time RT-PCR. The expected changes of p53, Sp3 and Klf4
expression were also confirmed by real time RT-PCR, with results similar to those shown in previous figures. (B) HeLa cells were transfected with
siRNAs for UBE3A, Klf4 and Sp3 alone or in combinations as indicated, in parallel with scrambled siRNA controls. UBE3A and Notch1 expression was
assessed by real-time RT-PCR. (C and D) Primary keratinocytes (HKC) (C) and HeLa and SCC13 cells (D were infected with a Klf4 expressing retrovirus or
empty vector control for 48 hours, followed by infection with the Adp53 or AdGFP viruses for 24 hours. Notch1 mRNA levels were assessed by real-
time RT-PCR.
doi:10.1371/journal.pone.0010369.g009
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Found at: doi:10.1371/journal.pone.0010369.s001 (0.07 MB
PDF)
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